Extensive telangiectases of the scalp: atypical presentation of primary cutaneous follicle centre lymphoma
S. Ingen-Housz-Oro,Meriem Jones,N. Ortonne,C. Haioun,O. Chosidow
DOI: https://doi.org/10.1111/j.1365-2141.2012.09205.x
2012-08-01
British Journal of Haematology
Abstract:A 65-year-old man was referred with a 1 cm subcutaneous nodule of the forehead (top left, arrow) surrounded by extensive telangiectases of the scalp that had appeared following trauma 3 years previously. Histology of both the nodule and telangiectases revealed a dense nodular lymphocytic infiltrate in the dermis, with a CD20+ (top right), CD10+, BCL6+ and BCL2+ immunophenotype. The skin, but not the blood, showed clonal immunoglobulin heavy chain gene (IGH@) rearrangement. A total body computed tomography scan, positron emission tomography, bone marrow examination, blood count and lactate dehydrogenase testing gave normal or negative results. The diagnosis of primary cutaneous follicle centre lymphoma was made. Staining with antibodies to CD31 and vascular endothelial growth factor A (VEGFA) showed increased numbers of normal vessels but no VEGFA expression in lymphocytes (bottom left). The patient received intravenous rituximab, 375 mg/m, once a week for 4 weeks, then one infusion every 2 months for 6 months. He showed both clinical (bottom right) and histological remission without relapse at 5 months follow-up. Telangiectases are common in poikilodermatous mycosis fungoides and intravascular lymphomas but not in cutaneous follicle centre lymphoma. In non-cutaneous follicular lymphomas, the prognostic role of angiogenesis remains controversial, and despite high rates of VEGFA expression in blood, tumour cells do not secrete the cytokine. Other cytokines, such as basic fibroblast growth factor, platelet-derived growth factor, epidermal growth factor, granulocyte colony-stimulating factor, interleukins 1, 6 and 8, and tumour necrosis factor a, could be involved. Extensive telangiectases of the scalp may be a feature of cutaneous follicle centre lymphoma. The pathophysiological mechanism and prognostic role of angiogenesis in cutaneous B-cell lymphomas remain to be elucidated.